B. Evana Ghassemi, PHARMD, BCACP, BCPS
@IBDPharmacist
Followers
620
Following
5K
Media
292
Statuses
2K
IBD Specialist #Clinicalpharmacist @UofTPharmacy @UF alumna #IBDPharmD IBDPatient Tweets are mine =Opinions 🚫medical advice 🇨🇦🇺🇸 #WomanLifeFreedom
California, USA
Joined April 2012
Roles of Clinical #PharmD in management of #IBD . @MondayNightIBD . #TwitteRx #GITwitter .#ClinicalPharmacist #IBD
2
7
33
RT @UmaMahadevanIBD: If you missed the @PIANOIBD Global Consensus Webinar today with me & @MLongMD, please go to t….
0
22
0
Currently listening to Dr. @UmaMahadevanIBD and Dr. @MLongMD on managing #IBD in pregnancy — excellent discussion on preconception planning, medication safety, and the latest insights from the PIANO study. 📊👩⚕️ #Gastroenterology #PIANOstudy.
On Wednesday, Aug. 13, at 12 p.m. PST, UCSF’s Dr. @UmaMahadevanIBD & @uncgastro’s Dr. Millie Long (@MLongMD) will host a webinar on how to manage inflammatory bowel disease (#IBD) in pregnancy. Register here:
1
1
4
RT @UmaMahadevanIBD: The @HelmsleyTrust @PIANOIBD Global Consensus Statement will be in print in early August! .Please join @MLongMD and m….
0
31
0
RT @DrAnuraagJ: Efficacy and Safety of Vedolizumab & Tofacitinib (VETO) Combination Therapy in Refractory UC Unresponsive to Anti-TNF and S….
0
20
0
RT @ibdtweets: 🎯 Extending the Half-Life of mAbs: Why It Matters in IBD. In Crohn’s disease and ulcerative colitis, therapeutic monoclonal….
0
21
0
This much-needed study 🧠📊 highlights how treatment efficacy in Crohn’s varies by disease location. Advanced therapies work much better in colonic CD vs. ileal — especially JAK inhibitors, which showed almost no benefit in ileal CD. #IBD
cghjournal.org
We compared the efficacy of different advanced therapies by disease location in patients with Crohn’s disease (CD) through a systematic review and meta-analysis.
0
0
3
RT @ShomronH: A bombshell metaanalysis just landed in @AGA_CGH : Advanced therpies work better in colonic #Crohn vs. Ileal dis 😱.aTNFs/a….
cghjournal.org
We compared the efficacy of different advanced therapies by disease location in patients with Crohn’s disease (CD) through a systematic review and meta-analysis.
0
48
0
RT @Bealoquebea: And with these latest data I updated the timeline including guselkumab . Feel free to use it at any time 😊 .
0
12
0
RT @Bealoquebea: 🔑ACG 2025 Preventive Care in IBD.Key Points:. ✅ Vaccinations:.- PCV20 or PCV21 instead of older schedules.- Shingrix (2-d….
0
55
0
Official journal of the American College of Gastroenterology | ACG
journals.lww.com
on for vaccinations are crucial because more than 70% of patients with IBD will at some time be on immune-modifying therapies that may increase the risk for infections, many of which are preventable...
0
0
0
RT @AmJGastro: New! ACG Clinical Guideline: Management of Crohn's Disease in Adults.Lichtenstein, et al. 📕 Guideline: .
0
31
0
RT @gastroendonews: The first study in The Regueiro Report this month is a post hoc analysis of two successful phase 3 trials, INSPIRE and….
0
1
0
RT @AmJGastro: In the #RedJournal:. HLA DQA1*05 and Risk of Antitumor Necrosis Factor Treatment Failure and Anti-Drug Antibody Development….
0
12
0
RT @UmaMahadevanIBD: Can we give MMR vaccine to IBD patients on immunosuppressive therapy? Maybe! Everyone has certainly been asking. Saf….
0
8
0
RT @charlie_lees: With a dozen advanced therapies on the market, are you confused about treating UC?. When is the right time to start advan….
0
17
0